Abstract

Immunosuppressive antibody therapy has been available since the 1960s, but it is only recently that such therapy has been used more widely. A number of exciting new antibody agents are poised to enter the market and it is likely that their use will increase in the near future. The potential role of these agents in the treatment of renal transplant recipients was discussed at the 32nd Annual Midyear Clinical Meeting of the American Society of Health Systems Pharmacists [Atlanta, US; December 1997].

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.